Fujifilm, ScreenPoint partner on AI for breast cancer detection

By AuntMinnie.com staff writers

August 16, 2021 -- Fujifilm Medical Systems USA and Dutch artificial intelligence (AI) software developer ScreenPoint Medical are partnering on AI for breast cancer detection.

The two firms will incorporate ScreenPoint Medical's Transpara fusion AI for 2D and 3D mammography software with Fujifilm's Aspire Cristalle mammography system with digital breast tomosynthesis (DBT).

Transpara includes the following applications:

  • Transpara Perception Aid, which marks findings directly for review
  • Transpara Decision Support, which allows radiologists to investigate suspicious regions while reading mammograms
  • Transpara Score, which categorizes mammograms in ten equally sized groups to predict malignancy

The U.S. Food and Drug Administration (FDA) cleared the software in 2020.


Copyright © 2021 AuntMinnie.com
 
Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: